endometrial cancer etiology
5月 16th, 2012 by qqmilkThe breakdown of endometrial cancer etiology
Endometrial carcinoma in the real causes are unknown to date,Cancer Treatment but the incidence of risk factors have long been noticed. Its risk factors:ocb1d2ccan
A fat, too much will increase estrogen storage, as well as the increase in plasma androstenedione two ketone into estrone. This free estrone increased with activity, may be carcinogenic factor of endometrial cancer, or cancer promoting factor.
In two, diabetes mellitus patients or sugar tolerance is not normal, the risk of endometrial cancer risk than normal people increased 2.8 times.
In three, hypertension, endometrial cancer patients with hypertension more.
Obesity, diabetes and hypertension three co-existed in endometrial cancer patients, referred to as” endometrial triad” or” endometrial carcinoma syndrome”. virtual officeThree may be associated with high fat diet and high fat diet, and endometrial cancer is directly related to.
In four patients with endometrial cancer, menstrual disorders, menstrual disorders, more than3 times higher, in normal women.
Five, early menarche and menopause later before the age of 12than12 years later menarche, endometrial cancer incidence is 60% more. Endometrial cancer is the vast light age than normal women6 years later.
Six, pregnant frequency endometrial cancer occurring in fertility, infertility, did not produce person more.
Seven, polycystic ovary syndrome is not ovulation, the endometrium at a high level, continuous estrogen function, lack of progesterone in regulating and periodic exfoliative endometrial hyperplasia, and change.
In eight, ovarian tumor secreted higher levels of estrogen in granular cell carcinoma, theca cell tumor, can cause irregular menstruation, postmenopausal bleeding and endometrial hyperplasia and endometrial carcinoma.
Nine, atypical hyperplasia of the endometrium for endometrial carcinoma a phase of development with or without this stage. And severe atypical hyperplasia, endometrial carcinoma in situ can be regarded as.
Ten, exogenous estrogen in women taking estrogen has a height of endometrial cancer risk, its risk and dose size, length of treatment, and whether the combination of progesterone, whether discontinuation, and the patient characteristics and other related. After the withdrawal of risk in the ash is reduced, company formationbut the danger of the ancient years continued. At present, estrogen and endometrial carcinoma a causal relationship between there is sufficient evidence.




